BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/7/2025 10:01:13 AM | Browse: 36 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 102347
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Lymph node metastatic patterns of gastric carcinoma with a combination of adenocarcinoma and neuroendocrine carcinoma components
Manuscript Source Unsolicited Manuscript
All Author List Kai Zhou, Zhong-Wu Li, Yan Wu, Zhi-Jie Wang, Ling-Qian Wang, Li-Xin Zhou, Ling Jia, Ke Ji, Xue-Song Yang, Ji Zhang, Xiao-Jiang Wu, An-Qiang Wang and Zhao-De Bu
Funding Agency and Grant Number
Funding Agency Grant Number
National Key Research and Development Program of China No. 2023YFF1204702
National Natural Science Foundation of China No. 82173151
Capital’s Funds for Health Improvement and Research No. CFH 2022-4-1025
Beijing Hospitals Authority Clinical Medicine Development of Special Funding No. XMLX202119
Science Foundation of Peking University Cancer Hospital No. PY202329
Corresponding Author Zhao-De Bu, PhD, Professor, Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Institute, No. 52 Fucheng Road, Haidian District, Beijing 100142, China. buzhaode@cjcrcn.org
Key Words Gastric mixed-adenoneuroendocrine carcinoma; Lymph node metastatic patteren; Clinicopathological features; Adjuvant chemotherapy regimens; Prognosis
Core Tip Rare individual studies on the lymph node metastasis components and treatment issues of adenoneuroendocrine mixed gastric cancer (G-ANEC). For G-ANEC, even if the neuroendocrine carcinoma (NEC) or adenocarcinoma (AC) component is relatively small in the primary lesion, it may still metastasize to the lymph nodes (LNs). If the metastasis in the LNs consists only of AC components, treatment of G-ANEC should primarily be based on fluoropyrimidine drugs. If the metastasis in the LNs includes NEC components, treatment should primarily be based on the etoposide and cisplatin/irinotecan and cisplatin regimen.
Citation

Zhou K, Li ZW, Wu Y, Wang ZJ, Wang LQ, Zhou LX, Jia L, Ji K, Yang XS, Zhang J, Wu XJ, Wang AQ, Bu ZD. Lymph node metastatic patterns of gastric carcinoma with a combination of adenocarcinoma and neuroendocrine carcinoma components. World J Gastroenterol 2025; 31(8): 102347

Received
2024-10-16 08:56
Peer-Review Started
2024-10-16 08:56
First Decision by Editorial Office Director
2024-11-30 04:54
Return for Revision
2024-11-30 04:54
Revised
2024-12-14 07:28
Publication Fee Transferred
2024-12-20 07:25
Second Decision by Editor
2025-01-07 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-01-07 10:01
Articles in Press
2025-01-07 10:01
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-01-11 13:57
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com